Stay updated on 24-Week Secukinumab Efficacy for Psoriatic Arthritis Clinical Trial
Sign up to get notified when there's something new on the 24-Week Secukinumab Efficacy for Psoriatic Arthritis Clinical Trial page.

Latest updates to the 24-Week Secukinumab Efficacy for Psoriatic Arthritis Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe page’s UI release marker was updated from revision v3.5.2 to v3.5.3, indicating a platform/version change without changing the underlying study information.SummaryDifference0.0%

- Check18 days agoChange DetectedRevision label updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check25 days agoNo Change Detected
- Check47 days agoChange Detected- Revision label updated from v3.4.3 to v3.5.0 on the page.SummaryDifference0.0%

- Check61 days agoChange DetectedSite revision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check82 days agoChange DetectedMinor system update shows Revision: v3.4.2 replacing v3.4.1; no impact on study details, eligibility criteria, locations, or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check90 days agoChange DetectedThe page shows a revision update from v3.4.0 to v3.4.1; this appears to be a minor backend/version update with no changes to the study content or user-facing features. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to 24-Week Secukinumab Efficacy for Psoriatic Arthritis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the 24-Week Secukinumab Efficacy for Psoriatic Arthritis Clinical Trial page.